M. Jerzak and P. Bischof, “Apoptosis in the First Trimester Human Placenta: The Role in Maintaining Privilege at the Matemal-Foetal Interface and the Trophoblast Remodeling,” The European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 100, 2002, pp. 138- 142. http://dx.doi.org/10.1016/S0301-2115(01)00431-6
 L. V. J. Schaffer, C. Breymann, M. Gassmann and H. H. Marti, “Preserved Placental Oxygenation and Development during Severe Systemic Hypoxia,” The American Journal of Physiology Regulatory, Integrative and Comparative Physiology, Vol. 290, No. 3, 2006, pp. 844-851. http://dx.doi.org/10.1152/ajpregu.00237.2005
 A. C. K. Ajakumar, “Expression, Ontogeny, and Regulation of Hypoxia-Inducible Transcription Factors in the Human Placenta,” Biology of Reproduction, Vol. 63, No. 2, 2000, pp. 559-569. http://dx.doi.org/10.1095/biolreprod63.2.559
 D. E. F. J. Ingber, “Mechanochemical Switching between Growth and Differentiation during Fibroblast Growth Factor-Stimulated Angiogenesis in Vitro: Role of Extracellular Matrix,” The Journal of Cell Biology, Vol. 109, No. 1, 1989, pp. 317-330.
 M. D. L. D. Mueller, E. Garrett and R. N. Taylor, “Neutrophils Infiltrating the Endometrium Express Vascular Endothelial Growth Factor: Potential Role in Endometrial Angiogenesis,” Fertility and Sterility, Vol. 74, No. 1, 2000, pp. 107-112.
 L. O. A. Hefler, P. Husslein, C. Kainz and C. Tempfer, “Vascular Endothelial Growth Factor Serum Levels in Pregnancy and Preeclampsia,” Acta Obstetricia et Gynecologica Scandinavica, 2000, pp. 77-78.
 S. N. K. aishi, N. Kinukawa, H. Nakano and K. Sueishi, “Immunohistochemical Localization of Vascular Endothelial Growth Factor in the Human Placenta,” Placenta, Vol. 17, No. 2-3, 1996, pp. 111-121.
 G. J. H. J. Burton and A. L. Wetson, “Maternal Arterial Connections to the Placectal Intervil Lous Space during the First Trimester of Human Pregnancy,” American Journal of Obstetrics & Gynecology, Vol. 181, 1999, p. 71.
 H. D. Z. J. Skinner, J. Fang, F. Agani and B. H. Jiang, “Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-Inducible Factor Lalpha, HDM2, and p74S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling,” The Journal of Biological Chemistry, Vol. 279, No. 44, 2004, pp. 45643-51.
 G. L. Bond, W. Hu, E. E. Bond, et al., “A Single Nucleotide Polymorphism in the MDM2 Promoter Attenustes the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans,” Cell, Vol. 119, 2004, pp. 591- 602.